Treatment of resistant Hodgkin's disease with CCNU, etoposide and prednimustine (CEP)

I Szántó1, T Fleischmann, S Eckhardt

  • 1Department of Hematology, National Institute of Oncology, Budapest, Hungary.

Oncology
|January 1, 1991
PubMed